MAPT and Alzheimer disease: A recent meta-analysis showed that cerebrospinal fluid Aβ and tau proteins alone were limited in the differential diagnosis of AD and other types of dementia (vascular dementia, frontotemporal dementia, and Lewy bodies dementia), with low sensitivity (70%-75%) and specificity (65%-80%).